ElMindA, is an Israeli company focusing on developing applications for the management of central nervous system diseases. ElMindA’s vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art Neuroscience into bed-side clinical practice. ElMindA’s technology records multi-channel EEG event-related potentials (ERPs), and a comprehensive multi-dimensional analysis of such recordings by advanced algorithms, aimed at understanding and visualizing the network complexity (or Brain Networks Activation patterns) of brain function, dysfunction, disease progression and response to therapeutic interventions. Thus far the technology has been approved for use in the drug development process with future applications for use in the management of concussions, ADHD, Alzheimer’s, pain, depression, Parkinson’s and migraine.

Read more about ElMindA here: http://www.elminda.com